On this episode of Stock Movers:

- Eli Lilly (LLY) said Monday it expects its highly anticipated weight-loss pill to receive US regulatory approval as early as the second quarter of 2026, slightly later than it signaled earlier. Drugmakers believe weight-loss pills could expand the market for popular GLP-1 medicines, which up until earlier this year were only sold as injections. In December, Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from Lilly.

- Shake Shack (SHAK) shares slipped after the burger chain reported preliminary fourth-quarter sales below Wall Street estimates. Preliminary revenue was $400.5 million, below the $409 million average estimate of analysts surveyed by Bloomberg, with Shake Shack blaming inclement weather for keeping diners away. Shake Shack expects sales to expand by low-single digits in 2026, compared with analyst expectations for 2.4% growth, and plans to open 95 to 105 company-operated and licensed locations this year.

- Abercrombie & Fitch (ANF) shares sank after holiday sales disappointed investors, helping spark a selloff in retail stocks. The company now expects fourth-quarter sales growth of around 5%, the mid-point of its prior range, and didn’t raise its outlook. Shares of Abercrombie plummeted 18% on Monday, while American Eagle and Urban Outfitters also sank after their holiday results underwhelmed Wall Street.

On this episode of Stock Movers: - Eli Lilly (LLY) said Monday it expects its highly anticipated weight-loss pill to receive US regulatory approval as early as the second quarter of 2026, slightly later than it signaled earlier. Drugmakers believe weight-loss pills could expand the market for popular GLP-1 medicines, which up until earlier this year were only sold as injections. In December, Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from Lilly. - Shake Shack (SHAK) shares slipped after the burger chain reported preliminary fourth-quarter sales below Wall Street estimates. Preliminary revenue was $400.5 million, below the $409 million average estimate of analysts surveyed by Bloomberg, with Shake Shack blaming inclement weather for keeping diners away. Shake Shack expects sales to expand by low-single digits in 2026, compared with analyst expectations for 2.4% growth, and plans to open 95 to 105 company-operated and licensed locations this year. - Abercrombie &amp; Fitch (ANF) shares sank after holiday sales disappointed investors, helping spark a selloff in retail stocks. The company now expects fourth-quarter sales growth of around 5%, the mid-point of its prior range, and didn&rsquo;t raise its outlook. Shares of Abercrombie plummeted 18% on Monday, while American Eagle and Urban Outfitters also sank after their holiday results underwhelmed Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Eli Lilly Rises, Shake Shack Declines, Abercrombie & Fitch Sinks

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2f78ae5a-7b55-4656-a492-b3d0016c4ad1/transcript